Tirante, Ruby .

HRN: 22-12-95  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2022
CEFTAZIDIME 1GM (VIAL)
11/04/2022
11/10/2022
IVT
1g
Q8
CAP-MR, T/C PTB Relapse
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: